EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Interfering with nucleotide excision by the coronavirus 3′-to-5′ exoribonuclease

Rukesh Chinthapatla, Mohamad Sotoudegan, Pankaj Srivastava, Thomas K Anderson, Ibrahim M Moustafa, Kellan T Passow, Samantha A Kennelly, Ramkumar Moorthy, David Dulin, Joy Y Feng iD, Daniel A Harki, Robert N Kirchdoerfer und 2 weitere

Nucleic Acids Research · 2023

DOI: 10.1093/nar/gkac1177 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2023. Verfasst von Rukesh Chinthapatla und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA. Hauptthemen laut MEDLINE: Antiviral Agents, Ribonucleotides, COVID-19 Drug Treatment. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Some of the most efficacious antiviral therapeutics are ribonucleos(t)ide analogs. The presence of a 3′-to-5′ proofreading exoribonuclease (ExoN) in coronaviruses diminishes the potency of many ribonucleotide analogs. The ability to interfere with ExoN activity will create new possibilities for control of SARS-CoV-2 infection. ExoN is formed by a 1:1 complex of nsp14 and nsp10 proteins. We have purified and characterized ExoN using a robust, quantitative system that reveals determinants of specificity and efficiency of hydrolysis. Double-stranded RNA is preferred over single-stranded RNA. Nucleotide excision is distributive, with only one or two nucleotides hydrolyzed in a single binding event. The composition of the terminal basepair modulates excision. A stalled SARS-CoV-2 replicase in complex with either correctly or incorrectly terminated products prevents excision, suggesting that a mispaired end is insufficient to displace the replicase. Finally, we have discovered several modifications to the 3′-RNA terminus that interfere with or block ExoN-catalyzed excision. While a 3′-OH facilitates hydrolysis of a nucleotide with a normal ribose configuration, this substituent is not required for a nucleotide with a planar ribose configuration such as that present in the antiviral nucleotide produced by viperin. Design of ExoN-resistant, antiviral ribonucleotides should be feasible.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsRibonucleotidesCOVID-19 Drug TreatmentHumansExoribonucleasesRNA, ViralSARS-CoV-2Viral Nonstructural ProteinsVirus ReplicationDrug Design

Substanzen

Antiviral AgentsExoribonucleasesRibonucleotidesRNA, ViralViral Nonstructural Proteins

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA.
  • Department of Biochemistry and Institute for Molecular Virology, University of Wisconsin-Madison, Madison, WI 53706, USA.
  • Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, PA 16802, USA.
  • Department of Medicinal Chemistry, University of Minnesota, Minneapolis, MN 55455, USA.
  • Department of Physics and Astronomy, and LaserLaB Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Junior Research Group 2, Interdisciplinary Center for Clinical Research, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Cauerstr. 3, 91058 Erlangen, Germany.

ORCID-Profile: Joy Y Feng, Craig E Cameron

Förderung

  • NIAID NIH HHS
  • NCI NIH HHS
  • NIGMS NIH HHS
  • National Institutes of Health
  • University of Minnesota, Office of the Vice President for Research
  • Interdisciplinary Center for Clinical Research
  • University Hospital of the University of Erlangen-Nuremberg
  • German Research Foundation

Zitieren

APA

Chinthapatla, R., Sotoudegan, M., Srivastava, P., Anderson, T. K., Moustafa, I. M., Passow, K. T., Kennelly, S. A., Moorthy, R., Dulin, D., Feng, J. Y., Harki, D. A., Kirchdoerfer, R. N., Cameron, C. E., & Arnold, J. J. (2023). Interfering with nucleotide excision by the coronavirus 3′-to-5′ exoribonuclease. Nucleic Acids Research. https://doi.org/10.1093/nar/gkac1177

Vancouver

Chinthapatla R, Sotoudegan M, Srivastava P, Anderson TK, Moustafa IM, Passow KT, et al. Interfering with nucleotide excision by the coronavirus 3′-to-5′ exoribonuclease. Nucleic Acids Research. 2023. doi:10.1093/nar/gkac1177

BibTeX
@article{Chinthapatla2023,
  author = {Chinthapatla, Rukesh and Sotoudegan, Mohamad and Srivastava, Pankaj and Anderson, Thomas K and Moustafa, Ibrahim M and Passow, Kellan T and Kennelly, Samantha A and Moorthy, Ramkumar and Dulin, David and Feng, Joy Y and Harki, Daniel A and Kirchdoerfer, Robert N and Cameron, Craig E and Arnold, Jamie J},
  title = {Interfering with nucleotide excision by the coronavirus 3′-to-5′ exoribonuclease},
  journal = {Nucleic Acids Research},
  year = {2023},
  doi = {10.1093/nar/gkac1177}
}
Kostenlos starten →